Actively Recruiting
Study of Dexrazoxane to Protect the Heart During Chemotherapy for Blood Cancers Including AML, MDS, CML, and Myeloproliferative Neoplasms
Led by M.D. Anderson Cancer Center · Updated on 2026-05-22
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how well dexrazoxane hydrochloride can prevent heart-related side effects caused by chemotherapy in people with various blood cancers, including acute myeloid leukemia, high-risk myelodysplastic syndrome, chronic myeloid leukemia in myeloid blast phase, Philadelphia chromosome-positive AML, and myeloproliferative neoplasms. This phase II trial aims to monitor heart function and related symptoms while participants receive chemotherapy combined with dexrazoxane. Participants receive treatment in three phases induction, consolidation, and maintenance. During induction, they receive gemtuzumab ozogamicin, cladribine, dexrazoxane hydrochloride, idarubicin, and cytarabine intravenously over specific days, repeated every 3-7 weeks for up to two courses. The consolidation phase involves similar drugs with adjusted schedules up to six courses. In the maintenance phase, participants in remission receive gemtuzumab ozogamicin every 2-3 months, dexrazoxane hydrochloride, idarubicin, and cytarabine subcutaneously for up to 32 months unless disease progresses or toxicity occurs. Throughout the study, participants are monitored for heart function using left ventricular ejection fraction measurements, cardiac symptoms, and blood levels of troponins. Researchers also collect safety data, remission rates, survival outcomes, and investigate molecular and environmental factors affecting response. Follow-up visits occur every 6 to 12 months after treatment completion to assess long-term outcomes and heart health.
CONDITIONS
Brief Title
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Research Team
M
Maro Ohanian
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here